ACUTAAS CHEMICALS LIMITED (ACUTAAS) financials

ACUTAAS CHEMICALS LIMITED (ACUTAAS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.[1]

Market Cap: ₹26,248Cr.
Current Price: ₹3,206
Stock P/E: 66.0
ROE: 24.4%
ROCE: 32.7%
Book Value: ₹204
Dividend Yield: 0.08%
52W High / Low: ₹3,740/1,570

In Jun 2026, ACUTAAS CHEMICALS LIMITED (ACUTAAS) reported sales ₹322 Cr and net profit ₹76 Cr.

Annual TTM: sales ₹1,440 Cr, net profit ₹397 Cr.

Shareholding: Promoters 32.66% (Sep 2026), FIIs 22.61% (Sep 2026), DIIs 19.40% (Sep 2026), Government 0.01% (Sep 2026), Public 25.31% (Sep 2026).

ACUTAAS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	244	271	304	206	305	391	422	322
Expenses	195	204	220	155	209	237	241	213
Operating Profit	48	67	84	51	97	154	181	110
OPM %	20%	25%	28%	25%	32%	39%	43%	34%
Other Income	9	2	6	16	9	6	15	4
Interest	0	1	0	1	1	1	1	1
Depreciation	6	6	7	7	8	9	9	9
Profit before tax	50	63	83	59	97	151	186	104
Tax %	25%	28%	24%	24%	25%	26%	26%	27%
Net Profit	38	45	63	45	73	112	137	76
EPS in Rs	4.60	5.53	7.67	5.45	8.90	13.63	16.74	9.27
Raw PDF	—	—	—	—	—	—	—	—

ACUTAAS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	240	341	520	617	688	990	1,324	1,440
Expenses	198	259	415	493	580	765	841	899
Operating Profit	42	81	105	123	108	225	483	542
OPM %	18%	24%	20%	20%	16%	23%	36%	38%
Other Income	2	0	3	4	-18	18	46	34
Interest	6	6	6	2	6	6	3	4
Depreciation	4	4	10	12	15	24	33	35
Profit before tax	35	72	91	112	69	214	493	538
Tax %	21%	25%	21%	26%	37%	25%	26%	—
Net Profit	27	54	72	83	44	160	366	397
EPS in Rs	4.36	8.57	9.87	11.43	5.92	19.48	44.73	48.54
Dividend Payout %	0%	0%	15%	13%	25%	8%	6%	—

ACUTAAS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	32	36	36	37	41	41
Reserves	71	97	132	482	550	638	1,271	1,627
Borrowings	54	59	137	1	3	203	11	32
Other Liabilities	77	61	110	136	169	193	215	235
Total Liabilities	212	228	410	655	759	1,071	1,538	1,935
Fixed Assets	58	62	161	178	222	357	499	601
CWIP	2	12	0	3	30	125	130	228
Investments	28	28	33	33	33	68	68	118
Other Assets	124	126	216	440	474	521	841	989
Total Assets	212	228	410	655	759	1,071	1,538	1,935

ACUTAAS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	22	27	26	-10	56	101	116	305
Cash from Investing Activity	-25	-24	-100	-122	-20	-337	-234	-334
Cash from Financing Activity	3	0	72	140	-14	235	274	4
Net Cash Flow	-0	3	-2	8	21	-1	155	-25
Free Cash Flow	4	8	-75	-42	-28	-205	-75	110
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	83%	85%	50%	12%	65%	109%	71%	86%

ACUTAAS shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	35.96%	35.96%	32.66%	32.66%	32.66%	32.66%	32.66%	32.66%
FIIs	15.52%	16.48%	16.94%	16.84%	16.67%	19.48%	21.61%	22.61%
DIIs	20.23%	18.31%	22.38%	22.59%	21.70%	19.60%	19.55%	19.40%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	28.27%	29.22%	28.00%	27.89%	28.96%	28.24%	26.16%	25.31%
No. of Shareholders	95,756	1,14,060	1,19,890	1,08,664	1,10,363	1,12,939	1,25,569	1,47,026

ACUTAAS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	113	80	127	113	136	113	107	99
Inventory Days	95	148	123	150	131	135	116	147
Days Payable	168	146	172	158	153	119	104	98
Cash Conversion Cycle	40	83	78	105	114	129	119	149
Working Capital Days	23	29	49	139	138	89	123	116
ROCE %	35%	27%	33%	24%	21%	14%	20%	33%

ACUTAASUpdated 18 Oct 2026, 23:41

Acutaas Chemicals Limited

ACUTAASUpdated 18 Oct 2026, 23:41

Market Cap

₹26,248Cr.

Current Price

₹3,206

High / Low

₹3,740/1,570

Stock P/E

66.0

ROE24.4%

ROCE32.7%

Book Value₹204

Face Value₹5.00

Dividend Yield0.08%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	142	1	117	1	3	23	25	17	2.31
Sep 2023	164	1	145	-30	3	-16	31	-21	-2.84
Dec 2023	162	3	138	3	4	20	23	16	2.13
Mar 2024	220	2	180	9	4	42	24	32	4.35
Jun 2024	171	4	145	2	6	18	25	14	1.68
Sep 2024	244	0	195	9	6	50	25	38	4.6
Dec 2024	271	1	204	2	6	63	28	45	5.53
Mar 2025	304	0	220	6	7	83	24	63	7.67
Jun 2025	206	1	155	16	7	59	24	45	5.45
Sep 2025	305	1	209	9	8	97	25	73	8.9
Dec 2025	391	1	237	6	9	151	26	112	13.63
Mar 2026	422	1	241	15	9	186	26	137	16.74
Jun 2026	322	1	213	4	9	104	27	76	9.27

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2017	160	3	137	0	1	19	35	12	1.91
Mar 2018	188	3	158	3	2	28	35	18	2.93
Mar 2019	236	5	193	1	3	37	33	25	3.91
Mar 2020	240	6	198	2	4	35	21	27	4.36
Mar 2021	341	6	259	0	4	72	25	54	8.57
Mar 2022	520	6	415	3	10	91	21	72	9.87
Mar 2023	617	2	493	4	12	112	26	83	11.43
Mar 2024	688	6	580	-18	15	69	37	44	5.92
Mar 2025	990	6	765	18	24	214	25	160	19.48
Mar 2026	1324	3	841	46	33	493	26	366	44.73
TTM	1440	4	899	34	35	538	—	397	48.54

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	32.66%
FIIs	22.61%
DIIs	19.4%
Government	0.01%
Public	25.31%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	39.91%	11.66%	7.58%	0%	40.85%
Mar 2024	39.91%	8.98%	6.8%	0%	44.31%
Jun 2024	35.98%	12.93%	14.81%	0%	36.28%
Sep 2024	35.97%	13.87%	19.93%	0%	30.24%
Dec 2024	35.96%	15.52%	20.23%	0.01%	28.27%
Mar 2025	35.96%	16.48%	18.31%	0.01%	29.22%
Jun 2025	32.66%	16.94%	22.38%	0.01%	28%
Sep 2025	32.66%	16.84%	22.59%	0.01%	27.89%
Dec 2025	32.66%	16.67%	21.7%	0.01%	28.96%
Mar 2026	32.66%	19.48%	19.6%	0.01%	28.24%
Jun 2026	32.66%	21.61%	19.55%	0.01%	26.16%
Sep 2026	32.66%	22.61%	19.4%	0.01%	25.31%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2017	2	38	26	43	109	14	11	15	68	109
Mar 2018	2	56	41	56	155	15	30	21	89	155
Mar 2019	10	71	54	77	212	58	2	28	124	212
Mar 2020	10	97	59	61	228	62	12	28	126	228
Mar 2021	32	132	137	110	410	161	0	33	216	410
Mar 2022	36	482	1	136	655	178	3	33	440	655
Mar 2023	36	550	3	169	759	222	30	33	474	759
Mar 2024	37	638	203	193	1071	357	125	68	521	1071
Mar 2025	41	1271	11	215	1538	499	130	68	841	1538
Mar 2026	41	1627	32	235	1935	601	228	118	989	1935

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2017	29	-19	-7	2
Mar 2018	10	-27	14	-2
Mar 2019	22	-25	3	0
Mar 2020	27	-24	0	3
Mar 2021	26	-100	72	-2
Mar 2022	-10	-122	140	8
Mar 2023	56	-20	-14	21
Mar 2024	101	-337	235	-1
Mar 2025	116	-234	274	155
Mar 2026	305	-334	4	-25

Key ratios

Historical financial ratios

Category	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	83	97	113	80	127	113	136	113	107	99
Inventory Days	76	89	95	148	123	150	131	135	116	147
Days Payable	148	154	168	146	172	158	153	119	104	98
Cash Conversion Cycle	11	31	40	83	78	105	114	129	119	149
Working Capital Days	46	59	23	29	49	139	138	89	123	116
ROCE %	—	38%	35%	27%	33%	24%	21%	14%	20%	33%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ACUTAAS CHEMICALS LIMITED (ACUTAAS)?

The reported market capitalisation for ACUTAAS CHEMICALS LIMITED (ACUTAAS) is ₹26,248Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ACUTAAS?

The current price shown for ACUTAAS CHEMICALS LIMITED (ACUTAAS) on Fincrux is ₹3,206 with a 52-week high/low of ₹3,740/1,570.

What is the P/E ratio of ACUTAAS CHEMICALS LIMITED (ACUTAAS)?

The stock P/E for ACUTAAS CHEMICALS LIMITED (ACUTAAS) is 66.0 on Fincrux, with ROE at 24.4% and ROCE at 32.7%.

What were ACUTAAS latest quarterly results?

For Jun 2026, ACUTAAS CHEMICALS LIMITED (ACUTAAS) reported sales ₹322 Cr and net profit ₹76 Cr (figures in ₹ crore unless noted).

What are ACUTAAS annual sales and net profit?

For TTM, ACUTAAS CHEMICALS LIMITED (ACUTAAS) shows sales of ₹1,440 Cr and net profit of ₹397 Cr on the Fincrux profit & loss statement.

Who owns ACUTAAS CHEMICALS LIMITED (ACUTAAS)?

Latest shareholding for ACUTAAS CHEMICALS LIMITED (ACUTAAS) on Fincrux: Promoters 32.66% (Sep 2026), FIIs 22.61% (Sep 2026), DIIs 19.40% (Sep 2026), Government 0.01% (Sep 2026), Public 25.31% (Sep 2026).

Where can I find ACUTAAS CHEMICALS LIMITED (ACUTAAS) financials?

ACUTAAS CHEMICALS LIMITED (ACUTAAS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ACUTAAS balance sheet and cash flow?

Yes. The ACUTAAS CHEMICALS LIMITED (ACUTAAS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 23:41